JP2007135456A - 清澄な、又は澱の発生しないdna含有飲料または液状食品の製造方法 - Google Patents
清澄な、又は澱の発生しないdna含有飲料または液状食品の製造方法 Download PDFInfo
- Publication number
- JP2007135456A JP2007135456A JP2005332688A JP2005332688A JP2007135456A JP 2007135456 A JP2007135456 A JP 2007135456A JP 2005332688 A JP2005332688 A JP 2005332688A JP 2005332688 A JP2005332688 A JP 2005332688A JP 2007135456 A JP2007135456 A JP 2007135456A
- Authority
- JP
- Japan
- Prior art keywords
- dna
- liquid food
- beverage
- starch
- clear
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 62
- 235000021056 liquid food Nutrition 0.000 title claims abstract description 54
- 238000004519 manufacturing process Methods 0.000 title claims description 18
- 150000007514 bases Chemical class 0.000 claims abstract description 26
- 238000004090 dissolution Methods 0.000 claims abstract description 17
- 239000003381 stabilizer Substances 0.000 claims abstract description 11
- 230000002378 acidificating effect Effects 0.000 claims description 23
- 239000004475 Arginine Substances 0.000 claims description 21
- 229960003121 arginine Drugs 0.000 claims description 21
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 21
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims description 16
- 239000000654 additive Substances 0.000 claims description 11
- 230000000996 additive effect Effects 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 7
- 239000004472 Lysine Substances 0.000 claims description 7
- 229960003646 lysine Drugs 0.000 claims description 7
- 241000251468 Actinopterygii Species 0.000 claims description 5
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 4
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 4
- 229960002442 glucosamine Drugs 0.000 claims description 4
- 229960002885 histidine Drugs 0.000 claims description 4
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 4
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 3
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 3
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 3
- 229960003104 ornithine Drugs 0.000 claims description 3
- 108020004414 DNA Proteins 0.000 description 122
- 102000053602 DNA Human genes 0.000 description 122
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 24
- 229920002472 Starch Polymers 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 239000008107 starch Substances 0.000 description 15
- 235000019698 starch Nutrition 0.000 description 15
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 102000011931 Nucleoproteins Human genes 0.000 description 9
- 108010061100 Nucleoproteins Proteins 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 235000015165 citric acid Nutrition 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 210000001550 testis Anatomy 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000001766 physiological effect Effects 0.000 description 6
- 229920002477 rna polymer Polymers 0.000 description 6
- 235000014102 seafood Nutrition 0.000 description 6
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 5
- 229960003589 arginine hydrochloride Drugs 0.000 description 5
- 230000003925 brain function Effects 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 235000011054 acetic acid Nutrition 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000005547 deoxyribonucleotide Substances 0.000 description 4
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000012827 research and development Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 3
- 241000972773 Aulopiformes Species 0.000 description 3
- 241000237503 Pectinidae Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000005352 clarification Methods 0.000 description 3
- 230000027832 depurination Effects 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000002777 nucleoside Substances 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000011007 phosphoric acid Nutrition 0.000 description 3
- 235000019515 salmon Nutrition 0.000 description 3
- 235000020637 scallop Nutrition 0.000 description 3
- 235000014214 soft drink Nutrition 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000252203 Clupea harengus Species 0.000 description 2
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 235000019514 herring Nutrition 0.000 description 2
- 235000011167 hydrochloric acid Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229960005337 lysine hydrochloride Drugs 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 125000003835 nucleoside group Chemical group 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 description 1
- GGTYBZJRPHEQDG-WCCKRBBISA-N (2s)-2,5-diaminopentanoic acid hydrochloride Chemical compound Cl.NCCC[C@H](N)C(O)=O GGTYBZJRPHEQDG-WCCKRBBISA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010056328 Hepatic ischaemia Diseases 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 241000277269 Oncorhynchus masou Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960001911 glucosamine hydrochloride Drugs 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229960003244 ornithine hydrochloride Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940048914 protamine Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 239000002213 purine nucleotide Substances 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 230000005313 thymus development Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
【解決手段】DNAの溶解安定剤として機能する塩基性化合物を併用して、DNAを清澄な飲料または液体食品に添加する。
【選択図】なし
Description
(1)コレステロール代謝への影響、離乳期の成長促進、脂肪代謝改善などの栄養改善効果がある。
(2)病気や癌に対する抵抗力増強、細胞活性の低下(老化防止)、リンパ系胸腺の発達促進などの免疫能改善効果がある。
(3)肝の再生、蛋白質の分解抑制、肝虚血時のエネルギー代謝の改善、肝障害に対する修復などの肝エネルギー代謝の賦活及び肝の再生効果がある。
(4)小腸粘膜の保護、下痢後の腸の回復などの腸管の保全効果がある。
(5)保湿効果、UV吸収の阻害、皮膚賦活などの皮膚に対する保護作用効果がある。
(6)老化に伴う脳機能の低下を抑制する効果がある。
1%高精製DNA(株式会社ニチロ製、Na塩、プロテアーゼ処理および活性炭処理により蛋白質を除去したもの、以下同じ)の水溶液に、アルギニン塩酸塩又はリジン塩酸塩をDNAに対して10、20、40及び100%(w/w)濃度となるように添加し、1Mクエン酸によりpH3.8に調整して、90℃で10分間加熱した。放冷後に40℃で保温し、溶状の変化を観察した。また、コントロールとして、DNAのみの試験区及びDNAのみで加熱処理しない試験区を設定した。
1%高精製DNA溶液を1Mクエン酸によりpH3.8に調整し、90℃で10分間加熱後、40℃で保温することにより生じた不溶物の成分分析を行った。不溶物には、DNAが3.4%、プリン塩基であるグアニンが82.6%、同じくプリン塩基であるアデニンが0.8%含まれており、不溶化の主な原因は酸性条件下で且つ加熱することによりDNAから遊離したグアニンが不溶物を形成するためと考えられた。
1%高精製DNA溶液に、アルギニン塩酸塩、リジン塩酸塩、ヒスチジン、オルニチン塩酸塩又はグルコサミン塩酸塩をDNA(モノマー換算)と等モル量(含量は順に0.56、0.50、0.42、0.46、0.58%(w/v))添加し、1Mクエン酸によりpH3.8に調整し、90℃で10分間加熱後、40℃で保温して溶状の変化を観察した。DNAのみの溶液は5日目に白濁するのが確認された。塩基性物質を添加した試験区はいずれも26日間清澄を維持した。
1%高精製DNA溶液、1%高精製DNA + 0.1% アルギニン塩酸塩溶液及び1%高精製DNA + 1% アルギニン塩酸塩溶液を、1Mクエン酸によりpH3.8に調整し、90℃で10分間加熱後、40℃で保温して溶状の変化を観察した。また、適宜サンプリングして、溶液中(不溶物発生サンプルは遠心分離して上清及び分析試薬で溶解した沈澱物中)のプリン塩基を定量した。
1%高精製DNA溶液にDNAと等重量のアルギニン塩酸塩を添加し、塩酸、クエン酸、リン酸、リンゴ酸、酢酸、乳酸又はアスコルビン酸によりpH3.8に調整した。90℃で10分間加熱後、40℃で保温して溶状の変化を観察した。その結果、アルギニン無添加区は5日目に濁りの発生が認められ、アスコルビン酸添加区は40日、クエン酸、リン酸及びリンゴ酸添加区は54日、乳酸、酢酸及び塩酸添加区は56日まで清澄かつ澱の無い溶液を維持した。
Claims (9)
- 清澄な、又は澱の発生しないDNA含有飲料または液状食品の製造方法において、DNA、DNAの溶解安定剤としての塩基性化合物及び水を含む酸性の飲料または液状食品を調製する工程と、前記飲料または液状食品を加熱殺菌して、清澄な、又は澱の発生しないDNA含有飲料または液状食品を得る工程を有することを特徴とする清澄な、又は澱の発生しないDNA含有飲料または液状食品の製造方法。
- 前記塩基性化合物が、アルギニン、リジン、ヒスチジン、オルニチン及びグルコサミンの少なくとも1種である請求項1に記載の製造方法。
- 前記塩基性化合物により得られるDNA溶解安定性が、酸性でのDNAからのプリン塩基の遊離を抑制することにより得られるものである請求項1または2に記載の製造方法。
- 前記DNAが魚介類由来のDNAである請求項1〜3のいずれかに記載の製造方法。
- 請求項1〜4のいずれかに記載の製造方法により得られたことを特徴とする清澄な、又は澱の発生しないDNA含有飲料または液状食品。
- 水を含む清澄な、又は澱の発生しない酸性の飲料または液状食品へのDNA添加用の添加剤において、DNAの溶解安定作用を有する塩基性化合物とDNAを含むことを特徴とする飲料または液状食品へのDNA添加用の添加剤。
- 前記塩基性化合物が、アルギニン、リジン、ヒスチジン、オルニチン及びグルコサミンの少なくとも1種である請求項6に記載の添加剤。
- 前記塩基性化合物は、酸性でのDNAからのプリン塩基の遊離を抑制してDNAの溶解安定性を得るものである請求項6または7に記載の添加剤。
- 前記DNAが魚介類由来のDNAである請求項6〜8のいずれかに記載の添加剤。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005332688A JP4111969B2 (ja) | 2005-11-17 | 2005-11-17 | 清澄な、又は澱の発生しないdna含有飲料または液状食品の製造方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005332688A JP4111969B2 (ja) | 2005-11-17 | 2005-11-17 | 清澄な、又は澱の発生しないdna含有飲料または液状食品の製造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007135456A true JP2007135456A (ja) | 2007-06-07 |
JP4111969B2 JP4111969B2 (ja) | 2008-07-02 |
Family
ID=38199056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005332688A Active JP4111969B2 (ja) | 2005-11-17 | 2005-11-17 | 清澄な、又は澱の発生しないdna含有飲料または液状食品の製造方法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4111969B2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009131222A (ja) * | 2007-11-30 | 2009-06-18 | Maruha Nichiro Foods Inc | 飲料への配合に適した核酸素材及びその製造方法 |
-
2005
- 2005-11-17 JP JP2005332688A patent/JP4111969B2/ja active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009131222A (ja) * | 2007-11-30 | 2009-06-18 | Maruha Nichiro Foods Inc | 飲料への配合に適した核酸素材及びその製造方法 |
Also Published As
Publication number | Publication date |
---|---|
JP4111969B2 (ja) | 2008-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liu et al. | Effects of dietary L-arginine or N-carbamylglutamate supplementation during late gestation of sows on the miR-15b/16, miR-221/222, VEGFA and eNOS expression in umbilical vein | |
CN101731665B (zh) | 一种鳄鱼组织的酶解方法及鳄鱼酒的制备方法 | |
Dias et al. | Soluble extracts from carioca beans (Phaseolus vulgaris L.) affect the gut microbiota and iron related brush border membrane protein expression in vivo (Gallus gallus) | |
CA2576516C (fr) | Additif alimentaire | |
EP1748705A1 (en) | Use of beta-cryptoxanthin | |
JP5114173B2 (ja) | 飲料への配合に適した核酸素材及びその製造方法 | |
JP4111969B2 (ja) | 清澄な、又は澱の発生しないdna含有飲料または液状食品の製造方法 | |
JP2009100728A (ja) | 消化力増強飼料、臭気軽減飼料、整腸剤型飼料、カロリー吸収率調整型飼料、肉質改善飼料、免疫力増強飼料、ならびに受胎率改善飼料、飼料型水質浄化剤、多機能性食品 | |
JP6862541B2 (ja) | 水棲動物用飼料 | |
CN107683974A (zh) | 一种促进雏鸡生长的保健型浓缩饮料及其制备方法 | |
JP3978716B2 (ja) | 遺伝子酸化損傷抑制剤 | |
JP6117963B2 (ja) | ポリアミンを有効成分とする、組織の再生を促進するための組成物 | |
JP7180935B1 (ja) | 液状飲料組成物 | |
JP2009039019A (ja) | ピリミジン系ヌクレオチド高含有酵母エキス及びその製造方法 | |
JP2003235504A (ja) | 耐久力増強剤 | |
JP5909173B2 (ja) | ポリアミンを有効成分とする、組織の再生を促進するための組成物 | |
JP2003144094A (ja) | 栄養補助食品又は飲料組成物 | |
RU2483567C1 (ru) | Кормовая биологически активная добавка для молодняка свиней | |
RU2559066C1 (ru) | Биологически активная добавка к пище | |
EP3397080A1 (en) | Nutritional compositions comprising hydrolyzed protein and uses thereof | |
US8420128B2 (en) | Method of imparting heat resistance to lactoferrin | |
JP6800733B2 (ja) | グルタチオン−s−転移酵素の発現促進剤および発現促進用食品組成物 | |
JP2024088899A (ja) | 非ヒト哺乳類の生産方法、非ヒト哺乳類の新生仔用乳組成物およびその生産方法、並びにこれらの応用 | |
JP7295609B2 (ja) | 栄養素吸収促進用食品組成物 | |
Wu et al. | Phosphate perils in marine aquaculture: Systematic toxicity assessment in turbot juveniles in cultivation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20071214 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071219 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080218 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20080218 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080326 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080408 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4111969 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110418 Year of fee payment: 3 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110418 Year of fee payment: 3 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130418 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130418 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140418 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |